Robert L. Evans
#167,561
Most Influential Person Now
Robert L. Evans's AcademicInfluence.com Rankings
Robert L. Evansbiology Degrees
Biology
#13663
World Rank
#17218
Historical Rank
Immunology
#954
World Rank
#978
Historical Rank
Download Badge
Biology
Robert L. Evans's Degrees
- PhD Immunology University of California, Berkeley
- Bachelors Biology University of California, Berkeley
Similar Degrees You Can Earn
Why Is Robert L. Evans Influential?
(Suggest an Edit or Addition)Robert L. Evans's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Endotoxin and double stranded RNA render macrophages cytotoxic. (1971) (475)
- Mechanism of Immunologically Specific Killing of Tumour Cells by Macrophages (1972) (420)
- Peripheral human T cells sensitized in mixed leukocyte culture synthesize and express Ia-like antigens (1978) (357)
- Thymus-dependent membrane antigens in man: inhibition of cell-mediated lympholysis by monoclonal antibodies to TH2 antigen. (1981) (348)
- Activation of human T lymphocyte subsets: helper and suppressor/cytotoxic T cells recognize and respond to distinct histocompatibility antigens. (1981) (321)
- MACROPHAGES IN SYNGENEIC ANIMAL TUMOURS (1972) (314)
- Cooperation of Immune Lymphoid Cells with Macrophages in Tumour Immunity (1970) (304)
- Antibodies to membrane structures that distinguish suppressor/cytotoxic and helper T lymphocyte subpopulations block the mixed leukocyte reaction in man (1981) (292)
- Identification of a p69,71 complex expressed on human T cells sharing determinants with B-type chronic lymphatic leukemic cells (1980) (281)
- Dissection of immunoregulatory subpopulations of T lymphocytes within the helper and suppressor sublineages in man. (1982) (236)
- Macrophage arginine metabolism and the inhibition or stimulation of cancer. (1992) (197)
- Effects of administration of progenipoietin 1, Flt-3 ligand, granulocyte colony-stimulating factor, and pegylated granulocyte-macrophage colony-stimulating factor on dendritic cell subsets in mice. (2002) (186)
- Two functionally distinct subpopulations of human T cells that collaborate in the generation of cytotoxic cells responsible for cell-mediated lympholysis. (1978) (179)
- Detection, isolation, and functional characterization of two human T- cell subclasses bearing unique differentiation antigens (1977) (138)
- Mechanisms of extracellular killing of nucleated mammalian cells by macrophages. (1976) (128)
- THYMUS-DERIVED LYMPHOCYTES PRODUCE AN IMMUNOLOGICALLY SPECIFIC MACROPHAGEARMING FACTOR (1972) (127)
- Characterization and expression of the HLA-DC antigens defined by anti-Leu 10. (1984) (116)
- Role of macrophages in tumour immunity. I. Co-operation between macrophages and lymphoid cells in syngeneic tumour immunity. (1972) (115)
- Mechanisms of experimental cancer cachexia. Interaction between mononuclear phagocytes and colon-26 carcinoma and its relevance to IL-6-mediated cancer cachexia. (1992) (115)
- IL-15 mediates anti-tumor effects after cyclophosphamide injection of tumor-bearing mice and enhances adoptive immunotherapy: the potential role of NK cell subpopulations. (1997) (101)
- Rendering macrophages specifically cytotoxic by a factor released from immune lymphoid cells. (1971) (100)
- Noncovalently bonded subunits of 22 and 28 kd are rapidly internalized by T cells reacted with anti-Leu-4 antibody. (1983) (94)
- Combination chemotherapy and IL-15 administration induce permanent tumor regression in a mouse lung tumor model: NK and T cell-mediated effects antagonized by B cells. (1998) (81)
- Spontaneous and induced leukemias of myeloid origin in recombinant inbred BXH mice (1984) (79)
- Role of tumor necrosis factor-alpha in the spontaneous development of pulmonary fibrosis in viable motheaten mutant mice. (1997) (71)
- Heterogeneity of human NK cells: comparison of effectors that lyse HSV-1-infected fibroblasts and K562 erythroleukemia targets. (1983) (64)
- Induction of T cell aggregation by antibody to a 16kd human leukocyte surface antigen. (1984) (54)
- In Situ Proliferation of Intratumor Macrophages (1984) (54)
- Inhibition of antibody-dependent cellular cytotoxicity and immunoglobulin synthesis by an antiserum prepared against a human B- cell Ia-like molecule (1976) (54)
- Blocking of human T lymphocyte functions by anti-Leu-2 and anti-Leu-3 antibodies: differential inhibition of proliferation and suppression. (1983) (50)
- Inhibition of 125IUdR incorporation by supernatants from macrophage and lymphocyte cultures: a cautionary note. (1976) (47)
- Interleukin 2-activated killer cells in patients following transplants of soybean lectin-separated and E rosette-depleted bone marrow. (1987) (47)
- CYTOTOXICITY OF MURINE PERITONEAL MACROPHAGES IN TUMOUR ALLOGRAFT IMMUNITY (1972) (47)
- Interleukin-2 production and response to interleukin-2 by peripheral blood mononuclear cells from patients after bone marrow transplantation: II. Patients receiving soybean lectin-separated and T cell-depleted bone marrow. (1987) (47)
- Combination therapy by using cyclophosphamide and tumor-sensitized lymphocytes: a possible mechanism of action. (1983) (46)
- Role of macrophages in tumour immunity. II. Involvement of a macrophage cytophilic factor during syngeneic tumour growth inhibition. (1972) (46)
- TUMOR MACROPHAGES IN HOST IMMUNITY TO MALIGNANCIES**This research was supported by grants from the Medical Research Council and the British Cancer Campaign. (1976) (43)
- In vitro interferon‐gamma production by cultured T‐cells in severe aplastic anaemia: correlation with granulomonopoietic inhibition in patients who respond to anti‐thymocyte globulin (1988) (42)
- Preparation of pure cultures of tumor macrophages. (1973) (41)
- Host cells in transplanted murine tumors and their possible relevance to tumor growth. (1979) (40)
- Tumor‐Derived Products Induce Il‐1 a, Il‐1 b, Tnf a, and Il‐6 Gene Expression in Murine Macrophages: Distinctions Between Tumor‐ and Bacterial Endotoxin‐Induced Gene Expression (1991) (37)
- Macrophages and the tumour bearing host. (1973) (37)
- Analysis of T-cell differentiation antigens in acute lymphatic leukemia using monoclonal antibodies. (1982) (36)
- IFN-gamma and IFN-alpha induce the expression and synthesis of Leu 13 antigen by cultured human endothelial cells. (1989) (36)
- Allocytotoxic T cell clones: both Leu 2+3− and Leu 2−3+ T cells recognize class I histocompatibility antigens (1983) (36)
- Phenotypes associated with tumor rejection mediated by cyclophosphamide and syngeneic tumor‐sensitized t lymphocytes: Potential mechanisms of action (1984) (36)
- Stability of RNA isolated from macrophages depends on the removal of an RNA-degrading activity early in the extraction procedure. (1990) (36)
- Characterization of B-cell type chronic lymphocytic leukemia cells by surface markers and a monoclonal antibody. (1982) (33)
- Antibody-dependent cellular cytotoxicity by allosensitized human T cells (1978) (33)
- Circulating interferon in mice infected with the lactate dehydrogenase-elevating virus. (1968) (32)
- Separation of antibody helper and antibody suppressor human T cells by using soybean agglutinin. (1980) (31)
- Further observations on the effect of cyclophosphamide on intratumor and peripheral leukocyte levels. (1980) (31)
- CSF‐1 (M‐CSF) differentially sensitizes mononuclear phagocyte subpopulations to endotoxin in vivo: a potential pathway that regulates the severity of Gram‐negative infections (1998) (30)
- The interplay of lymphoid cells and macrophages in tumour immunity. (1972) (30)
- The potential role of the macrophage colony‐stimulating factor, CSF‐1, in inflammatory responses: characterization of macrophage cytokine gene expression (1995) (29)
- Synergistic interaction of bacterial lipopolysaccharide and the monocyte‐macrophage colony‐stimulating factor: potential quantitative and qualitative changes in macrophage‐produced cytokine bioactivity (1992) (29)
- The immunological network at the site of tumor rejection. (1986) (28)
- Immunologically Specific Activation of Macrophages Armed with the Specific Macrophage Arming Factor (SMAF) 1 (1973) (28)
- Multiple effector roles of lymphocytes in allograft immunity. (1973) (27)
- Regulation of Systemic Macrophage IL‐1 Gene Transcription: The Involvement of Tumor‐Derived Macrophage Growth Factor, CSF‐1 (1989) (23)
- Modifications of the guanidine hydrochloride procedure for the extraction of RNA: isolation from a variety of tissues and adherent/nonadherent cell types. (1992) (22)
- Differential sensitivity of mouse mononuclear phagocytes to CSF-1 and LPS: the potential in vivo relevance of enhanced IL-6 gene expression. (1996) (22)
- DIFFERENTIATION OF IMMUNOLOGICALLY SPECIFIC CYTOTOXIC MACROPHAGES INTO TWO TYPES ON THE BASIS OF RADIOSENSITIVITY (1974) (22)
- Non-specific cytotoxicity of spleen cells in mice bearing transplanted chemically induced fibrosarcomas. (1977) (21)
- Macrophages and neoplasms: new insights and their implication in tumor immunobiology (2004) (21)
- Activities of macrophages within and peripheral to the tumor mass. (1983) (21)
- Tumor‐associated macrophages stimulate the proliferation of murine tumor cells surviving treatment with the oncolytic cyclophosphamide analogue ASTA Z‐7557: In vivo implications (1984) (20)
- Amplification of immune T lymphocyte function in situ: the identification of active components of the immunologic network during tumor rejection. (1985) (18)
- The immunological basis of tumor rejection: the absolute dependence of the effector arm on sensitized T cells after chemoimmunotherapy of a murine sarcoma. (1985) (18)
- Ultrastructural, cytochemical and biochemical changes occurring during syngeneic macrophage-lymphoma interaction in vitro. (1972) (18)
- STUDIES ON THE MECHANISM OF ACTION OF RILEY VIRUS (1965) (17)
- Lack of correlation between in vivo rejection of syngeneic fibrosarcomas and in vitro non-specific macrophage cytotoxicity. (1978) (17)
- Role of macrophages in tumour immunity. 3. Co-operation between macrophages and lymphoid factors in an in vitro allograft situation. (1972) (16)
- CSF‐1 regulation of I6 gene expression by murine macrophages: a pivotal role for GM‐CSF (1998) (16)
- Cytokine release by macrophages after interacting with CSF-1 and extracellular matrix proteins: characteristics of a mouse model of inflammatory responses in vitro. (1998) (16)
- A monoclonal antibody that induces T cell aggregation reacts with vascular endothelial cells and placental trophoblasts. (1986) (15)
- A serum-derived molecule from autoimmune viable motheaten mice potentiates the action of a B cell maturation factor. (1985) (15)
- Macrophage accumulation in primary and transplanted tumors growing in C5‐deficient B10.D2/oSn mice (1980) (15)
- Replication of Riley's plasma enzymes elevating virus in tissue culture: the importance of the cellular composition. (1967) (14)
- Tumor-infiltrating leukocytes. (1985) (14)
- Phagocytosis of murine lymphoma cells by macrophages. II. Differences between opsonic and cytotoxic activity of mice immunized with lymphoma cells. (1971) (12)
- Regulation of T‐ and B Lymphocyte Responses to Mitogens by Tumor‐Associated Macrophages: The Dependency on the Stage of Tumor Growth (1984) (12)
- Clonal expression of differentiation and Ia‐like antigens on alloreactive human T lymphocytes (1984) (12)
- Intratumor gene expression after adoptive immunotherapy in a murine tumor model. Regulation of messenger RNA levels associated with the differential expansion of tumor-infiltrating lymphocytes. (1993) (12)
- Phagocytosis of murine lymphoma cells by macrophages. I. Factors affecting in vitro phagocytosis. (1971) (11)
- Distribution of tumor‐sensitized cells during the induction of permanent tumor regression by chemoimmunotherapy: The use of glucose phosphate isomerase as a marker (1984) (11)
- Priming of mouse macrophages with the macrophage colony-stimulating factor (CSF-1) induces a variety of pathways that regulate expression of the interleukin 6 (Il6) and granulocyte-macrophage colony-stimulating factor (Csfgm) genes. (1997) (11)
- Tumor cell IL‐6 gene expression is regulated by IL‐1α/β and TNFα: proposed feedback mechanisms induced by the interaction of tumor cells and macrophages (1992) (11)
- CSF-1 (M-CSF) Enhances the Inflammatory Response of Fibronectin-Primed Macrophages: Pathways Involved in Activation of the Cytokine Network (2000) (11)
- Differential in situ expansion and gene expression of CD4+ and CD8+ tumor‐infiltrating lymphocytes following adoptive immunotherapy in a murine tumor model system (1991) (11)
- Further Studies on the Replication of the Lactate Dehydrogenase-Elevating Virus (LDH Virus) in Mouse Peritoneal Macrophage Cultures (1970) (10)
- Expression of Class II‐MHC Antigens by Tumor‐Associated and Peritoneal Macrophages: Systemic Induction During Tumor Growth and Tumor Rejection (1986) (10)
- The role of the inflammatory response during tumor growth. (1982) (9)
- The detection of Ia-like and DRw antigens on activated T cells. (1979) (9)
- The therapeutic efficacy of murine anti-tumor T cells: freshly isolated T cells are more therapeutic than T cells expanded in vitro. (1995) (8)
- Cellular basis for regulation of tumor growth. (1980) (8)
- Relationship between concomitant immunity and metastasis - the role of macrophages in concomitant immunity involving the peritoneal cavity. (1973) (8)
- CSF-1-induced and constitutive Il6 gene expression in mouse macrophages: evidence for PKC-dependent and -independent pathways. (1997) (7)
- An electron microscopic study of lactic dehydrogenase virus in cultures of mouse peritoneal macrophages. (1967) (6)
- Qualitative and quantitative intratumoral changes in gene expression following cyclophosphamide injection and the adoptive transfer of t cells: The potential contribution of tumor‐associated macrophages (1994) (5)
- Evidence for and against a beneficial role of tumor-associated immunity. (1982) (5)
- Clarification of the Potential Role of CSF‐1 in Activation of Macrophages (1991) (4)
- Activation of the IL-1 pathway during amplification of immune responses in tumor-bearing mice. (1987) (4)
- Changes in tumor-associated NK 1.1+ large granular lymphocyte precursors after cyclophosphamide injection: in vitro characterization and potential therapeutic application. (1994) (4)
- Mechanisms of immunologically specific killing of tumor cells by macrophages. [Nature 1972; 236:168-70. Citation classic]. (1985) (3)
- Identification with the monoclonal antibody 26.163 of a determinant shared by the beta chains of the gene products of the HLA-DR, DQ, and DP loci. (1986) (3)
- Partial characterization of a low-molecular-weight, macrophage-derived inhibitor of DNA synthesis: a possible immunoregulatory molecule. (1989) (3)
- Adoptive immunotherapy is suppressed in C57BL/6J AND B6.C‐H‐2bm12 mice following recognition of congenic class II MHC antigen determinants (1989) (2)
- Cytotoxicity of fibrosarcoma macrophages to mouse lymphoma cells in presence of alloantibody. (1974) (2)
- Cellular basis for regulation of tumor growth, p. 255-266. In isaac p. Witz and m. G. Hanna, jr. [eds.] Contemporary topics in immunobiology, vol. 10. New york, plenum publ. (1980) (2)
- The immunological mouse mutants nude (nu) and rhino (hrrh) generate cytotoxic effector cells following adoptive immunotherapy but fail to reject a transplanted tumor (2004) (1)
- Factors affecting replication of the lactate dehydrogenase-elevating virus (LDH virus) in peritoneal macrophage. (1969) (1)
- Multiparameter Approaches to FACS Analysis of Human Leucocyte Cell Surface Antigens (1984) (1)
- by B Cells NK and T Cell-Mediated Effects Antagonized Regression in a Mouse Lung Tumor Model: Administration Induce Permanent Tumor Combination Chemotherapy and IL-15 (1998) (0)
- 954 HUMORAL IMMUNE RESPONSE IN VITRO AFTER BONE MARROW TRANSPLANTATION (BMT) (1981) (0)
- Cultivation and in vitro characterization of mouse phagocytic cells. (1970) (0)
- HLA typing of lymphocyte subpopulations for the identification of intrauterine-derived engrafted maternal cells in patients with severe combined immunodeficiency (SCID) (1982) (0)
- #338 Improved survival in murine rhabdomyosarcoma by FLT 3 ligand enhanced CD4+ and CD8+ T-cell infiltration of tumors (1999) (0)
- Studies on riley's plasma lactate dehydrogenase (ldh) elevating virus (rv). Growth rate of tumours in rv-infected mice. (1964) (0)
- Chapter 10 – Dual Recognition by Coupled Receptors in a Model of T Lymphocyte Differentiation1 (1983) (0)
- marrow Patients receiving soybean lectin-separated and T cell-depleted bone mononuclear cells from patients after bone marrow transplantation: II. Interleukin-2 production and response to interleukin-2 by peripheral blood (2013) (0)
- Specimen Sample Preservation for Cell and Tissue Cultures (1996) (0)
- Enhanced Lysis of [125l]5‐lodo‐2′‐ Deoxyuridine‐Labeled Target Cells in the Presence of Normal Macrophages: Possible Mechanisms of Action (1985) (0)
- Monoclonal antibody to a helper T-cell marker (Leu-3) blocks HLA-DR dependent T-cell functions (1982) (0)
- The Immunomodulatory Effects of Vitamin D on Mononuclear Phagocytes (2014) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Robert L. Evans?
Robert L. Evans is affiliated with the following schools:
